4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-020161
Exec. VP, European Commercial sold 1,297 shares at $16.64 ($21,588)
- Exec. VP, European Commercial acquired 1,297 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Daniell Richard · Exec. VP, European Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-17 | Exercise or conversion : show line 1 in the form | +1,297 | 1,297 | D | ||
| 2019-03-18 | Sale : show line 2 in the form | −1,297 | $16.64 | $21,588 | 0 | D |
| Open-market sales · 1,297 sh · avg $16.64 · $21,588 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-17 | Exercise or conversion : show line 3 in the form Restricted Share Units | −1,297 | 1,297 | D |
Loading xslF345X03/doc4.xml…